10.28.15
The Society for Women’s Health Research strongly urges Congress to pass the Bipartisan Budget Act of 2015
The Bipartisan Budget Act of 2016 replaces sequestration equally for both defense and nondefense over the next two years. Failure to pass this critical legislation will hinder scientific discovery, compromise public health programs, and delay patients’ access to innovative medical treatments.
10.26.15
GAO Finds NIH Has Made Progress Including Women in Research, But Improved Reporting And Analysis Needed
The Government Accountability Office (GAO) released a report, showing that more work needs to be done in reporting and analysis policies to further ensure women and minorities are being accurately represented in clinical trials.
10.16.15
School Bathroom Habits Impact Life-Long Bladder Health: Opening the Door to the Girls’ Room
This year, SWHR launched its Interdisciplinary Network on Urological Health in Women to promote bladder and urinary tract health across a woman's lifespan.
10.13.15
SWHR Earns Coveted 4-Star Rating From Charity Navigator
SWHR earned a 4-star rating from premier independent charity evaluator organization Charity Navigator, which rates more than 8,000 nonprofits nationally on their accountability, transparency, and fiscal responsibility.
9.24.15
The Flu Shot: It’s Not Just For Kids
Adults, children, pregnant women -- everyone! -- older than six months should get a flu shot every year.
9.22.15
The Society For Women’s Health Research Welcomes New Board Member
SWHR is excited to announce the appointment of a new member to its Board of Directors. Joining the Board is Shontelle Dodson, PharmD, vice president of Medical Excellence within Medical Affairs, Global, at Astellas Pharma Inc.
9.17.15
SWHR Supports Dr. Robert Califf’s Nomination to Lead FDA
President Barack Obama has nominated distinguished cardiologist and medical researcher Dr. Robert Califf to be the next U.S. Food and Drug Administration (FDA) Commissioner.
8.18.15
SWHR Supports FDA Decision to Approve Female Sexual Dysfunction Treatment
SWHR applauds the Food and Drug Administration (FDA) on the approval of Flibanserin, the first ever medical treatment option for Hypoactive Sexual Desire Disorder (HSDD).
8.17.15
The Society for Women’s Health Research Announces Three New Board Members
SWHR is excited to announce the appointment of three new members to its Board of Directors, Nieca Goldberg, MD, Bruce McEwen, PhD., and David Page, MD.
